drugset

drugset / Trial / NCT02787746

Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease

NCT02787746 ↗

Phase 4 Completed 241 enrolled Beijing Friendship Hospital Eisai China Inc. · collab Xuanwu Hospital, Beijing · collab

NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the safety and Efficacy of donepezil in treatment of AD patients in China.

Timeline

Start: 2016-04
Primary completion: 2019-01
Completion: 2019-03

Publications

Jia J, Wei C, Chen W, Jia L, Zhou A, Wang F, Tang Y, Xu L. Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease. J Alzheimers Dis. 2020;74(1):199-211. doi: 10.3233/JAD-190940.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Donepezil	Small molecule	10 mg	—

Indications